Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.2 |
mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |